Glenview Trust Co’s Merck & Co Inc Position
Does Glenview Trust Co own Merck & Co Inc (MRK)? Yes — 376.9K shares worth $45M (+0.71% of its 13F portfolio) as of Q1 2026, up from 367.3K shares the prior filed quarter.
Position Value
$45M
Q1 2026
Shares
376.9K
% of Portfolio
+0.71%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 376.9K | $45M | +0.71% |
| Q4 2025 | 367.3K | $39M | +0.60% |
| Q3 2025 | 367.4K | $31M | +0.49% |
| Q2 2025 | 369.9K | $29M | +0.51% |
| Q1 2025 | 371.5K | $33M | +0.65% |
| Q4 2024 | 342.0K | $34M | +0.64% |
| Q3 2024 | 356.3K | $40M | +0.78% |
| Q2 2024 | 343.5K | $43M | +0.86% |
| Q1 2024 | 338.4K | $45M | +0.96% |
| Q4 2023 | 321.8K | $35M | +0.86% |
| Q3 2023 | 319.1K | $33M | +0.91% |
| Q2 2023 | 311.5K | $36M | +0.98% |
| Q1 2023 | 308.9K | $33M | +0.98% |
| Q4 2022 | 301.3K | $33M | +1.11% |
| Q3 2022 | 287.8K | $25M | +0.94% |
| Q2 2022 | 275.9K | $25M | +0.92% |
| Q1 2022 | 263.5K | $22M | +0.70% |
| Q4 2021 | 244.1K | $19M | +0.62% |
| Q3 2021 | 243.4K | $18M | +0.71% |
| Q2 2021 | 237.7K | $18M | +0.71% |
| Q1 2021 | 223.4K | $17M | +0.74% |
| Q4 2020 | 209.2K | $17M | +0.80% |
| Q3 2020 | 207.9K | $17M | +0.89% |
| Q2 2020 | 204.7K | $16M | +0.90% |
| Q1 2020 | 185.1K | $14M | +0.99% |
| Q4 2019 | 178.0K | $16M | +0.91% |
| Q3 2019 | 177.1K | $15M | +0.90% |
| Q2 2019 | 171.3K | $14M | +0.89% |
| Q1 2019 | 155.6K | $13M | +0.83% |
| Q4 2018 | 143.0K | $11M | +0.81% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenview Trust Co’s full portfolio or all institutional holders of MRK.